QCLS insider filings

Q/C TECHNOLOGIES, INC. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen QCLS transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Silverman Joshua — Executive Chairman, Director2——4
PharmaCyte Biotech, Inc. — 10% owner1——3
Ehrlichman Yossef — Chief Technology Officer1———

Recent insider filings — Q/C TECHNOLOGIES, INC.

FiledFormInsiderReported transactionsSource
2026-11-204PharmaCyte Biotech, Inc. — 10% ownerOption exercise/expiry (X): 4,982,272 @ $0 · Option exercise/expiry (X): 851,304 (derivative) @ $0 · Other (J): 3,000 (derivative) @ $0EDGAR
2026-10-024/ASilverman Joshua — Executive Chairman, DirectorGrant/award (A): 16,806 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-10-024Silverman Joshua — Executive Chairman, DirectorGrant/award (A): 16,620 @ $0 · Grant/award (A): 77,390 @ $0EDGAR
2026-09-223Ehrlichman Yossef — Chief Technology OfficerHoldings only — no transactions reportedEDGAR
2026-05-144Voss Chelsea Sierra — DirectorPurchase (P): 1,753 @ $3.15EDGAR
2026-04-154White Billy Joe — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-154Voss Chelsea Sierra — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-154Silverman Joshua — Executive Chairman, DirectorGrant/award (A): 162,162 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-04-154Glass Mitchell — Chief Medical Officer, DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-154Friscia Stephen — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-04-154Bernstein Bruce — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-01-304Voss Chelsea Sierra — DirectorGrant/award (A): 212,500 @ $0 · Grant/award (A): 25,000 @ $0 · Grant/award (A): 212,500 (derivative) @ $0EDGAR
2025-11-184PharmaCyte Biotech, Inc. — 10% ownerPurchase (P): 889,865 (derivative) · Purchase (P): 889,865 (derivative)EDGAR
2025-11-174Glass Mitchell — Director, Chief Medical Off., DirectorGrant/award (A): 11,420 @ $0EDGAR
2025-11-174White Billy Joe — DirectorGrant/award (A): 22,839 @ $0EDGAR
2025-11-144Silverman Joshua — Executive Chairman, DirectorGrant/award (A): 91,356 @ $0EDGAR
2025-11-144Friscia Stephen — DirectorGrant/award (A): 22,839 @ $0EDGAR
2025-11-144Bernstein Bruce — DirectorGrant/award (A): 25,000 @ $0EDGAR
2025-11-144RAUCH GARY MGrant/award (A): 11,420 @ $0EDGAR
2025-10-064White Billy Joe — DirectorGrant/award (A): 2,161 @ $0EDGAR
2025-10-064Silverman Joshua — Executive Chairman, DirectorGrant/award (A): 8,644 @ $0EDGAR
2025-10-064RAUCH GARY MGrant/award (A): 1,080 @ $0EDGAR
2025-10-064Glass Mitchell — Director, Chief Medical Off., DirectorGrant/award (A): 1,080 @ $0EDGAR
2025-10-064Friscia Stephen — DirectorGrant/award (A): 2,161 @ $0EDGAR

Recent 8-K events — Q/C TECHNOLOGIES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K1.01 — Entry into a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-138-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-09-188-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K1.02 — Termination of a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K1.02 — Termination of a Material Definitive Agreement
8.01 — Other Events
EDGAR
2026-03-138-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-238-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-098-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-068-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=QCLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs